openPR Logo
Press release

IVF service market is expected to reach $ 829.5 million in 2023, with a CAGR of 18.2% | Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd. and oth

03-26-2019 11:05 AM CET | Health & Medicine

Press release from: Allied Market Research

IVF service market

IVF service market

The IVF service market in India is expected to grow considerably in the future due to an increase in the incidence of infertility cases, an increase in the tendency of women to delay pregnancy, and an increase in spouse donations. In addition, inexpensive clinical settings for IVF treatment in India compared to IVF treatment facilities in the US, UK and other pre-existing markets, market growth with rising popularity of medical and fertilizer tourism combined with advanced IVF facilities and treatment options.

The IVF service market in India is valued at $ 260 million in 2016 and is expected to reach $ 829.5 million in 2023, with a CAGR of 18.2% from 2017 to 2023. Contemporary lifestyle, increased infertility rates between couples, increased median spending Advanced and advanced classes for IVF treatment are key factors driving market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2172

In terms of end users, the Infertility Clinic sector accounted for approximately 61% of India's IVF services market revenue in 2016 and is expected to remain dominant over the forecast period. The segment also performed 77.4 million cycles in 2016, reaching 245.4 million units by 2023, with an annual average growth rate of 17.9%, the highest number of IVF cycles. This is due to the fact that infertility clinics offer a broad range of technically advanced infertility treatments under a single roof for patients.

Depending on the type of cycle, the new IVF cycle segment (non-donors) has the highest sales of $ 181.1 million in 2016 and has grown to $ 1,620 million, or $ 1,620 million, is expected. In addition, this sector is expected to reach 239.600 cycles by 2023, with a fresh IVF cycle (non-donor) of 80.1 million in 2016 in the IVF service market in India, growing by 16.9% annually from 2017 to 2023.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2172

Key Findings of the India Ivf Services Market:
• Based on cycle type, in 2016, fresh IVF cycle (non-donor) segment accounted for around 70% share of the total market, in terms of revenue
• Thawed IVF cycle (non-donor) is projected to be the one of the fastest growing segments, registering a CAGR of 19.6% from 2017 to 2023, in terms of revenue
• Based on gender, in 2016, the female infertility segment, in terms of volume, accounted for more than 70% share of the total market.
• Based on IVF procedures, in 2016, non-ICSI IVF accounted for the highest revenue, thereby registering a CAGR of 19.2% from 2017 to 2023.

The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes profiled in this report include Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd., Southend Fertility and IVF Centre, Nova IVI Fertility, Bloom Fertility Center, Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann, and Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.).

Other players (profiles not included in the report) in the value chain analysis include, Apollo Hospitals, Fortis Hospitals, Ruby Hall IVF & Endoscopy Center., and others.

Access Full Summery @ https://www.alliedmarketresearch.com/india-ivf-services-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IVF service market is expected to reach $ 829.5 million in 2023, with a CAGR of 18.2% | Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd. and oth here

News-ID: 1671833 • Views: 481

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for IVF

Veterinary IVF Market to Witness Huge Growth by 2027 | IVF Limited, Planer, Mini …
HTF Market Intelligence released a new research report of 100 pages on title 'Europe Veterinary IVF Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2027' with detailed analysis, forecast and strategies. The study covers key regions that includes IVF Limited , Planer, Minitube, Hamilton Thorne Inc., Equine Fertility Center and important players such as Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Belgium, Russia, Turkey, Rest of
Best IVF Specialists in Pune
IVF is also known as test tube baby treatment, which has helped those couples who are unable to conceive their baby through natural process. During this procedure, female eggs are retrieved from her ovaries and are made to mix with sperms in the lab. Multiple embryos are formed during the procedure, which are transferred back into the woman’s uterus. IVF Experts in Pune are highly trained and take care of their
India IVF Treatment Market Outlook 2018
India has a large population of 1.22 Billion people and infertility in the country is rising at a rapid rate (about 30 Million couples suffer from infertility). Infertility or the inability to have children refers to a range of disorders some of which affect the male, and some the female, and contribute to childlessness in a couple. There is also something called unexplained infertility, where doctors are unable to provide
UAE IVF Treatment Market Outlook 2018
UAE has been projected as one of the upcoming IVF market meeting all international health expectations and standards in terms of quality of services provided without discrimination. It bears a potential to become a hub for promoting medical tourism keeping in mind the recent changes that have been introduced by the government, healthcare facilities that meet international standards and the well qualified doctors that are willing to serve here. The country
UK IVF Services Market
According to a new report published by Allied Market Research titled, UK IVF Services Market by End User and Cycle Type: Opportunity Analysis and Industry Forecast, 2014-2022, the UK IVF services market is estimated to reach $685.4 million by 2022, registering a CAGR of 7.7% from 2016 to 2022. The UK IVF services market is characterized by important factors such as increase in cases of infertility, delayed marriages, and parenthood decisions.
04-12-2017 | Health & Medicine
TMR
Global In Vitro Fertilization (IVF) Market
In vitro fertilization (IVF) has today emerged as one of the most preferred choices for individuals and couples with problems of infertility. This assisted reproductive method is also widely popular among single mothers and individuals from the LGBT community. Rising cases of infertility, recent innovations in IVF procedures, an emerging trend of delayed pregnancies among women, favorable reimbursement scenarios, and the surge in disposable income and health-care spending have significantly